SHENZHEN, China I 14, 2025 I Kexing Biopharm Co., Ltd. (Stock Code: 688136.SH) recently announced that the Investigational New Drug Application (IND) ...

The new drug candidate for FSHD will combine an RNA molecule from miRecule targeting double homeobox 4 (DUX4) – a protein that is mutated in FSHD – with a nanobody developed by Sanofi that ...

In this study, we critically evaluate the nanobody epitope prediction performance of two leading models: AlphaFold3 and AlphaFold2-Multimer (v.2.3.2), highlighting their strengths and limitations. Our ...

It’s a drug that Ploos van Amstel helped to launch ... This and its smaller size – it’s a “nanobody” that is only a fraction of the size of conventional antibodies – could allow ...

Feb. 5, 2025 — A new study has found that certain bacteria were associated with better memory and attention, while others were linked to an increased risk of Alzheimer's ... Scientists Reveal ...

Feb. 11, 2025 — A recent study by two biological science researchers found that a pathogen for bird pink eye remained viable on bird feeders in winter months much ... 'Junk' RNA Segments Play ...

The influenza A virus genome consists of eight segments of single-stranded, negative-sense viral RNA, which encode multiple ...

Need to identify a tablet or capsule? Use our Pill Identifier to find the name and image of an unknown prescription or over-the-counter medication. Start by entering details like pill imprint code ...

Initial data from the Phase 1 trial expected in 2025 SAN FRANCISCO, CALIFORNIA, Jan. 27, 2025 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company”) (NASDAQ: GTBP), a clinical stage immuno ...